StevenBDeitelzweigMDphysician

PubMed

• Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation.
  Kang, A., Jiang, J., Gao, C., Luo, X., Atreja, N., Han, S., Cheng, D., Loganathan, S., Lip, G., Deitelzweig, S.> ;Journal of Clinical Medicine. 2024 Feb 14
• Journey to anticoagulant access following payer rejection of apixaban.
  Steven Deitelzweig, Lin Xie, Emi Terasawa, David Weber Hood, Matthew Cato, Nipun Atreja, Amiee Kang, Dionne M Hines> ;The American Journal of Managed Care. 2023 Nov 1
• 1 citations
  Payer formulary tier increases of apixaban: how patients respond and potential implications.
  Steven Deitelzweig, Emi Terasawa, Nipun Atreja, Amiee Kang, Dionne M Hines, Amol D Dhamane, Melissa Hagan, Ahmed Noman, Xuemei Luo> ;Current Medical Research and Opinion. 2023 Aug 1
• Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study.
  Steven Deitelzweig, Allison Keshishian, Amiee Kang, Aaron Jenkins, Nipun Atreja, Patricia Schuler, Jenny Jiang, Huseyin Yuce, Xiaoxi Sun, Gregory Y H Lip> ;European Journal of Internal Medicine. 2023 Feb 1
• 1 citations
  Healthcare utilization differences between an apixaban-based and warfarin-based strategy for acute venous thromboembolism in patients with end-stage kidney disease.
  Shirin Ardeshirrouhanifard, Michael I Ellenbogen, Jodi B Segal, Michael B Streiff, Steven B Deitelzweig, Daniel J Brotman> ;Thrombosis Research. 2023 Jan 1
• 3 citations
  Payer formulary exclusions of apixaban: how patients respond and potential implications.
  Steven Deitelzweig, Emi Terasawa, Amiee Kang, Nipun Atreja, Dionne M Hines, Ahmed Noman, Xuemei Luo> ;Current Medical Research and Opinion. 2022 Nov 1
• 3 citations
  Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19.
  Steven Deitelzweig, Julia Zhu, Jenny Jiang, Xuemei Luo, Allison Keshishian, Mauricio Ferri, Lisa Rosenblatt, Patricia Schuler, Cynthia Gutierrez, Amol D Dhamane> ;Current Medical Research and Opinion. 2022 Nov 1
• 6 citations
  Safety and effectiveness of apixaban versus warfarin for acute venous thromboembolism in patients with end-stage kidney disease: A national cohort study.
  Michael I Ellenbogen, Shirin Ardeshirrouhanifard, Jodi B Segal, Michael B Streiff, Steven B Deitelzweig, Daniel J Brotman> ;Journal of Hospital Medicine. 2022 Oct 1
• 2 citations
  Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
  Gregory Y H Lip, Richard R Murphy, Farhad Sahiar, Timothy J Ingall, Amol D Dhamane, Mauricio Ferri, Patrick Hlavacek, Madison T Preib, Allison Keshishian, Cristina Rus...> ;JAMA Network Open. 2022 Aug 1
• 4 citations
  Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative cla...
  Gregory Y H Lip, Allison Keshishian, Amiee Kang, Xuemei Luo, Nipun Atreja, Yan Zhang, Patricia Schuler, Jenny Jiang, Huseyin Yuce, Steven Deitelzweig> ;Journal of Thrombosis and Thrombolysis. 2022 Jul 1
• 26 citations
  Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum.
  Geoffrey D Barnes, Allison Burnett, Arthur Allen, Jack Ansell, Marilyn Blumenstein, Nathan P Clark, Mark Crowther, William E Dager, Steven B Deitelzweig, Stacy Ellswor...> ;Journal of Thrombosis and Thrombolysis. 2022 Aug 1
• 8 citations
  Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis.
  Steven Deitelzweig, Evelien Bergrath, Manuela di Fusco, Amiee Kang, Mirko Savone, Joseph C Cappelleri, Cristina Russ, Marissa Betts, Allie Cichewicz, Kassandra Schaibl...> ;Future Cardiology. 2022 May 1
• 29 citations
  Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer
  Steven Deitelzweig, Allison Keshishian, Yan Zhang, Amiee Kang, Amol D Dhamane, Xuemei Luo, Christian Klem, Mauricio Ferri, Jenny Jiang, Huseyin Yuce, Gregory Y.H. Lip> ;JACC. Cardiooncology. 2021 Sep 1
• 22 citations
  Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients with High Risk of Gastrointestinal Bleeding
  Gregory Y.H. Lip, Allison Keshishian, Yan Zhang, Amiee Kang, Amol D Dhamane, Xuemei Luo, Christian Klem, Mauricio Ferri, Jenny Jiang, Huseyin Yuce, Steven Deitelzweig> ;JAMA Network Open. 2021 Aug 2
• Response to a letter by Jolobe: ARISTOPHANES subgroup analysis of frail and older patients with NVAF receiving low doses of novel oral anticoagulants
  Gregory Y.H. Lip, S. Deitelzweig> ;Journal of Internal Medicine. 2021 May 17
• 4 citations
  Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity
  Steven Deitelzweig, Allison Keshishian, Amiee Kang, Amol D Dhamane, Xuemei Luo, Christian Klem, Lisa Rosenblatt, Jack Mardekian, Jenny Jiang, Huseyin Yuce, Gregory Y.H...> ;Advances in Therapy. 2021 May 7
• 16 citations
  Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients.
  Steven Deitelzweig, Allison Keshishian, Amiee Kang, Amol D Dhamane, Xuemei Luo, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Jenny Jiang, Huseyin Yuce, Gregor...> ;Therapeutic Advances in Gastroenterology. 2021 Mar 21
• 4 citations
  Real-world persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis
  Steven Deitelzweig, Manuela Di Fusco, Amiee Kang, Mirko Savone, Ruth Mokgokong, Allison Keshishian, Cynthia Gutierrez, Joseph C. Cappelleri> ;Current Medical Research and Opinion. 2021 Apr 16
• 57 citations
  Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study
  Jason B. Hill, David A. Garcia, Mark Crowther, Bryan Savage, Shira Peress, Kevin J. Chang, Steven Deitelzweig> ;Blood Advances. 2020 Nov 10
• 3 citations
  Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA.
  Steven Deitelzweig, Amol D Dhamane, Manuela Di Fusco, Cristina Russ, Lisa Rosenblatt, Melissa Lingohr-Smith, Jay Lin> ;Journal of Medical Economics. 2020 Oct 19
• 1 citations
  Major bleed costs of atrial fibrillation patients treated with factor Xa inhibitor anticoagulants
  Gregory J. Fermann, Belinda Lovelace, Mary J. Christoph, Melissa Lingohr-Smith, Jay Lin, Steven Deitelzweig> ;Journal of Medical Economics. 2020 Oct 27
• 14 citations
  Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy.
  Gregory Y.H. Lip, Allison Keshishian, Amiee Kang, Amol D Dhamane, Xuemei Luo, Christian Klem, Lisa Rosenblatt, Jack Mardekian, Jenny Jiang, Huseyin Yuce, Steven Deitel...> ;European Heart Journal. Cardiovascular Pharmacotherapy. 2021 Sep 21
• 2 citations
  Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major...
  Steven Deitelzweig, Belinda Lovelace, Mary J. Christoph, Melissa Lingohr-Smith, Jay Lin, Gregory J. Fermann> ;Advances in Therapy. 2020 Jul 22
• 298 citations
  Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum.
  Geoffrey D. Barnes, Allison Burnett, Arthur Allen, Marilyn Slavin Blumenstein, Nathan P. Clark, Adam Cuker, William E. Dager, Steven Deitelzweig, Stacy Ellsworth, Davi...> ;Journal of Thrombosis and Thrombolysis. 2020 Jul 1
• 1 citations
  Budget impact analysis of betrixaban for venous thromboembolism prophylaxis in nonsurgical patients with acute medical illness in the United Kingdom
  Holly Guy, Vicki Laskier, Mark Fisher, Iwona Bucior, Steven Deitelzweig, Alexander T. Cohen> ;Expert Review of Pharmacoeconomics & Outcomes Research. 2020 May 3
• Join now to see all

Abstracts/Posters

• [Board 280] Comparison of Major Bleeding and Stroke-Related Hospital Readmissions Among Hospitalized Nonvalvular Atrial Fibrillation Patients Treated With Warfarin and...
  Steven Deitelzweig, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019

Lectures

• Differences in Admission Rates Among Patients Treated with Apixaban Vs. Warfarin for Venous Thromboembolism in the Emergency Department 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Among Frail Nonvalvular Atrial Fibrillation Patients 
  2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019